EVH Evolent Health Inc

  1. Stocks
  2. Healthcare
  3. NYSE: EVH

Price (delayed)

$4.8

Market cap

$539.91M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$4.68

Enterprise value

$1.36B

?
Relative Growth: Rel. Growth: 28
Relative Strength: Rel. Strength: 68
Relative Valuation: Rel. Valuation: 39
Relative Profitability: Rel. Profitability: 7

Evolent Health delivers proven clinical and administrative solutions that improve whole-person health while making health care simpler and more affordable. Its solutions encompass total cost of care management, specialty care ...

Highlights
The quick ratio has grown by 32% YoY
The EPS rose by 8% QoQ
The gross margin has grown by 33% YoY but it has contracted by 5% from the previous quarter
EVH's gross profit is down by 4.7% since the previous quarter but it is up by 4.2% year-on-year
The company's equity has shrunk by 58% YoY and by 4.5% QoQ
The revenue has contracted by 21% YoY
Sector: Healthcare
Industry: Health Information Services
Website: http://www.evolenthealth.com
Peers: NHC CPRT GHC ARMK

Key stats

What are the main financial stats of EVH

EVH stock price

How has the Evolent Health stock price performed over time
Intraday
7.14%
1 week
2.13%
1 month
21.52%
1 year
-54.29%
YTD
20%
QTD
110.53%

Financial performance

How have Evolent Health's revenue and profit performed over time
Revenue
$1.89B
Gross profit
$381.19M
Operating income
-$412.34M
Net income
-$527.72M
Gross margin
20.2%
Net margin
-27.9%
The gross margin has grown by 33% YoY but it has contracted by 5% from the previous quarter
The revenue has contracted by 21% YoY
EVH's gross profit is down by 4.7% since the previous quarter but it is up by 4.2% year-on-year
The net margin has increased by 2.1% QoQ

Price vs fundamentals

How does EVH's price correlate with its fundamentals

Growth

What is Evolent Health's growth rate over time

Valuation

What is Evolent Health stock price valuation
P/E
N/A
P/B
1.35
P/S
0.28
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.72
The EPS rose by 8% QoQ
The company's equity has shrunk by 58% YoY and by 4.5% QoQ
EVH's price to book (P/B) is 55% lower than its 5-year quarterly average of 2.8 but 15% higher than its last 4 quarters average of 1.1
The price to sales (P/S) is 83% lower than the 5-year quarterly average of 1.6 and 33% lower than the last 4 quarters average of 0.4
The revenue has contracted by 21% YoY

Efficiency

How efficient is Evolent Health business performance
The ROE has contracted by 12% from the previous quarter
EVH's return on invested capital is up by 11% since the previous quarter
The ROS rose by 3.1% QoQ

Dividends

What is EVH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for EVH.

Financial health

How did Evolent Health financials performed over time
The company's total assets is 27% higher than its total liabilities
The company's current ratio rose by 35% YoY
The quick ratio has grown by 32% YoY
The debt is 149% higher than the equity
EVH's debt to equity has surged by 168% year-on-year and by 4.6% since the previous quarter
The company's equity has shrunk by 58% YoY and by 4.5% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.